Koers China Resources Pharmaceutical Group Limited
Aandelen
3320
HK0000311099
Farmaceutische producten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,76 HKD | -1,65% | +2,37% | -7,21% |
Omzet 2023 | 245 mld. 31,22 mld. 29,34 mld. | Omzet 2024 * | 283 mld. 36,1 mld. 33,92 mld. | Marktkapitalisatie | 30,41 mld. 3,88 mld. 3,65 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | 3,85 mld. 492 mln. 462 mln. | Nettowinst (verlies) 2024 * | 4,6 mld. 587 mln. 552 mln. | EV/omzet 2023 | 0,28 x |
Nettoschuld 2023 | 36,2 mld. 4,62 mld. 4,34 mld. | Nettoschuld 2024 * | 33,97 mld. 4,33 mld. 4,07 mld. | EV/omzet 2024 * | 0,23 x |
K/w-verhouding 2023 |
8,41
x | K/w-verhouding 2024 * |
6,68
x | Werknemers | 72.986 |
Dividendrendement 2023 |
3% | Dividendrendement 2024 * |
3,43% | Vrij verhandelbaar | 27,95% |
1 dag | -1,65% | ||
1 week | +2,37% | ||
Lopende maand | -4,80% | ||
1 maand | -9,16% | ||
3 maanden | +3,25% | ||
6 maanden | +0,63% | ||
Lopend jaar | -7,21% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Song Bai
CEO | Chief Executive Officer | 52 | 14-01-22 |
Rong Hui Deng
DFI | Director of Finance/CFO | 46 | 13-06-23 |
Yue Wei Han
CHM | Chairman | 56 | 22-10-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rui Fang Jiao
BRD | Director/Board Member | 47 | 14-01-22 |
Ting Mei Fu
BRD | Director/Board Member | 56 | 01-06-16 |
Ke Jian Zhang
BRD | Director/Board Member | 68 | 20-06-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.92% | 4 M€ | -27,92% | ||
0.52% | 2 M€ | -20,02% | - | |
0.12% | 4 M€ | -11,56% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 4,76 | -1,65% | 9 368 078 |
22-04-24 | 4,84 | +1,04% | 8 786 161 |
19-04-24 | 4,79 | +2,13% | 9 671 566 |
18-04-24 | 4,69 | -1,47% | 8 822 548 |
17-04-24 | 4,76 | +2,37% | 7 428 000 |
uitgestelde koers Hong Kong S.E., 23 april 2024 om 09:49 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,21% | 3,88 mld. | |
+25,46% | 659 mld. | |
+25,45% | 557 mld. | |
-4,86% | 359 mld. | |
+16,44% | 322 mld. | |
+8,34% | 297 mld. | |
+6,52% | 215 mld. | |
+7,53% | 210 mld. | |
-6,01% | 200 mld. | |
-8,79% | 149 mld. |